Alumni raised $1.45B in 2022 - Download Free Report Now

BioLineRx (TASE: BLRX)

Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI).

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of BioLineRx (TASE: BLRX) plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About BioLineRx (TASE: BLRX)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups


Companies We Work With